Seven Water Tanks to be Rehabilitated, One to be Constructed in 2025
Pennsylvania American Water unveils $6.2 million water storage tank upgrade plan during Infrastructure Week
MECHANICSBURG, Pa., May 12, 2025--(BUSINESS WIRE)--In conjunction with the start of the annual Infrastructure Week observation, Pennsylvania American Water today announced its 2025 tank infrastructure investment plan, including the rehabilitation of seven of its existing water storage tanks and the construction of one new tank. Pennsylvania American Water's tank rehabilitation program of inspecting, sandblasting and repainting tanks extends the tanks' service lives and helps protect water quality. The total expected cost of the company's water storage upgrades and construction this year is approximately $6.2 million.
"Storage tanks are a critical part of our distribution system infrastructure," said Tony Nokovich, vice president of engineering at Pennsylvania American Water. "Tanks provide system capacity to residential and commercial customers, along with adequate pressure and fire protection. Maintaining and rehabilitating tanks extends their service life and is more cost-efficient than replacing them."
This year, the company will rehabilitate and repaint seven storage tanks in the following municipalities:
Municipality
County
Cost
Size (gal)
Butler Township
Butler
$630,000
250,000
Clarks Green Township
Lackawanna
$288,000
300,000
Coolbaugh Township
Monroe
$429,000
400,000
Neshannock Township
Lawrence
$530,000
300,000
Neshannock Township
Lawrence
$720,000
1,100,000
White Deer Township
Union
$507,000
503,000
White Township
Indiana
$1,700,000
200,000
To rehabilitate the tanks, crews will strip the original paint and apply a new coating, which serves as a protective barrier that prevents steel from rusting and impacting water quality. During tank rehabilitation, customers should not experience impacts on their water service.
The company is also constructing a new ground storage tank in Fairview Township, York County, to provide additional water storage capacity, which will help the company continue to deliver reliable water service to meet customer demand and provide fire protection. With a construction cost of $1.4 million, the tank will have a capacity of 208,000 gallons.
These infrastructure projects are not only an important investment in public health and safety, they also help support the economic vitality of the community. Economic impact studies show that for every $1 million invested in water infrastructure, upwards of 15 jobs are generated throughout the economy. Statewide, Pennsylvania American Water invested approximately $675 million in 2024 alone to improve its water and wastewater treatment and pipeline systems, supporting more than 10,125 jobs. The company's 2025 tank rehabilitation and construction projects will support more than 90 jobs.
"At Pennsylvania American Water, we take pride in continuously maintaining and upgrading the infrastructure that helps Keep Life Flowing for our customers," said the company's president, Justin Ladner. "To provide high-quality, reliable water and wastewater services, we're committed to the proper planning, careful implementation, and of course, investment dollars that are necessary to ensure our systems operate safely and efficiently."
To learn more about Pennsylvania American Water's infrastructure investment efforts, visit pennsylvaniaamwater.com/infrastructure.
About American Water
American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to more than 14 million people with regulated operations in 14 states and on 18 military installations. American Water's 6,700 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders.
For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram.
About Pennsylvania American Water
Pennsylvania American Water, a subsidiary of American Water, is the largest regulated water utility in the state, providing safe, clean, reliable and affordable water and wastewater services to approximately 2.4 million people.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250512260481/en/
Contacts
Media Contact: David MisnerSenior Manager, External Communications717-262-7525david.misner@amwater.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
30 minutes ago
- Business Wire
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. ( (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced positive data from a Phase 1b trial in celiac disease for lead program FB102 (FB102-101). The company will be hosting a conference call today at 8:30 am ET. Prof. Jason Tye-Din, Head of Celiac Research at the Walter and Eliza Hall Institute and principal investigator in the FB102-101 study will be participating in the call. Please connect to the call using the following link: The event and accompanying slides can also be accessed by visiting the investor relations section of the company's website at An archived webcast will be available on the company's website following the event. The FB102-101 Phase 1b celiac disease study enrolled 32 subjects 3:1 randomized (24 on FB102 and 8 on placebo). Subjects received 4 doses of FB102 (10 mg/kg) and underwent a 16 day gluten challenge. In addition to safety and tolerability, the study assessed morphologic and inflammatory endpoints along with gluten challenge (GC) induced symptoms. FB102 demonstrated a statistically significant benefit on the composite histological VCIEL endpoint (change from baseline). The mean VCIEL change from baseline was -1.849 for placebo subjects compared to 0.079 for FB102 treated subjects (p=0.0099). The change in the density of CD3-positive T cells, or IELs, from baseline was an increase of 13.3 for placebo subjects compared to a decline of 1.5 for FB102 treated subjects (p=0.0035). Baseline IEL density was 25.6 for the placebo subjects and 23.5 for the FB102 treated subjects. The mean change in the Vh:Cd ratio from baseline was -0.173 (0.21) for placebo subjects compared to -0.046 (0.09), a 73% improvement for FB102 treated subjects compared to placebo. Gluten challenge induced GI symptoms (nausea, vomiting, diarrhea, abdominal pain and abdominal bloating) reported during the 16 day gluten challenge from patient diaries/AE collection demonstrated a 42% benefit for FB102 treated subject (4.0 events per subject) compared to placebo (6.9 events per subject). There were no dropouts in the study. Treatment emergent adverse events (TEAE) were primarily mild (grade 1) with no grade 3 or higher SAEs reported in the FB102 arm. 'We want to congratulate all of the investigators and researchers that supported this study. I also want to acknowledge the incredible dedication and hard work of the Forte team. Celiac disease is debilitating for many patients with even trace exposure to gluten. FB102 has taken a big step forward towards addressing this very large unmet need with the results from this study. The Phase 2 celiac disease study is initiating with a topline readout expected in 2026.' said Paul Wagner, Ph.D. CEO and Chairperson of Forte Biosciences. 'These results are also very encouraging given the biology of the additional FB102 indications including vitiligo, alopecia areata and type 1 diabetes. We also look forward to reading out the topline results of the FB102 vitiligo study in the first half of 2026.' About Forte Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company that is advancing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. Forward-Looking Statements Forte cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as 'may,' 'will,' 'should,' 'expect,' 'plan,' 'anticipate,' 'could,' 'intend,' 'target,' 'project,' 'contemplates,' 'believes,' 'estimates,' 'predicts,' 'potential' or 'continue' or the negatives of these terms or other similar expressions. These statements are based on the Forte's current beliefs and expectations. Forward-looking statements include statements regarding Forte's beliefs, goals, intentions and expectations regarding its product candidate, FB102 and the therapeutic and commercial market potential of FB102, the expected timeline for the Phase 2 celiac study and related readout, and the expected timing of topline results for the FB102 vitiligo study. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation: risks related to Forte's ability to obtain sufficient additional capital to continue to advance Forte's product candidate, FB102; uncertainties associated with the clinical development and regulatory approval of Forte's product candidate, FB102, including potential delays in the commencement, enrollment and completion of clinical trials; the risk that results from preclinical and the Phase 1b trials may not be predictive of future results from clinical trials; risks associated with the failure to realize any value from FB102 in light of inherent risks, expense and difficulties involved in successfully bringing product candidates to market; and additional risks, uncertainties, and other information affecting Forte's business and operating results is contained in Forte's Quarterly Report on Forms 10-Q filed on May 15, 2025, and in its other filings with the Securities and Exchange Commission. All forward-looking statements in this press release are current only as of the date hereof and, except as required by applicable law, Forte undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Source: Forte Biosciences, Inc.
Business Wire
43 minutes ago
- Business Wire
NPK Announces New $150 Million Revolving Credit Facility
THE WOODLANDS, Texas--(BUSINESS WIRE)--NPK International Inc. (NYSE: NPKI) ('NPK' or the 'Company') today announced that it has entered into a new credit agreement ('Agreement') effective June 20, 2025, which includes a $150 million revolving loan facility, replacing the Company's previous asset-based revolving credit facility. The Agreement has a term of five years and also includes an accordion feature, allowing for the expansion of the revolving loan facility up to $250 million. Under the terms of the Agreement, revolving loans bear interest at either Term SOFR plus 175 to 225 basis points or the Base Rate plus 75 to 125 basis points, with the applicable margin determined based on the Company's consolidated leverage ratio, as calculated in accordance with the Agreement. The bank group participating in the facility includes Bank of America, N.A., Amegy Bank, Regions Bank, First Horizon Bank, Texas Capital Bank and Woodforest National Bank. Gregg Piontek, NPK's Senior Vice President and Chief Financial Officer, stated, "We are very pleased to have the support of our bank group, including our long-term partners, as well as new partnerships established through this Agreement. The new facility provides expanded liquidity and improved flexibility, better enabling us to execute on our long-term growth strategy and capital allocation priorities, consistent with our focus on driving long-term value creation for our shareholders." For further information regarding the Agreement, please refer to the Company's Current Report on Form 8-K, to be filed with the Securities and Exchange Commission on or before June 26, 2025. ABOUT NPK INTERNATIONAL NPK International Inc. is a worksite access solutions company that manufactures, sells, and rents industry-leading sustainable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The Company delivers superior quality and reliability across critical infrastructure markets, including electrical transmission & distribution, oil and gas exploration, pipeline, renewable energy, petrochemical, construction, and other industries. For more information, visit our website at FORWARD-LOOKING STATEMENTS This news release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements other than statements of historical facts are forward-looking statements. Words such as 'will,' 'may,' 'could,' 'would,' 'should,' 'anticipates,' 'believes,' 'estimates,' 'expects,' 'plans,' 'intends,' 'guidance,' and similar expressions are intended to identify these forward-looking statements but are not the exclusive means of identifying them. These statements are not guarantees that our expectations will prove to be correct and involve a number of risks, uncertainties, and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents filed with the Securities and Exchange Commission by NPK, particularly its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q, as well as others, could cause actual plans or results to differ materially from those expressed in, or implied by, these statements. These risk factors include, but are not limited to, risks related to our sale of the Fluids Systems business; our ability to generate organic growth; economic and market conditions that may impact our customers' future spending; the effective management of our fleet, including our ability to properly manufacture, safeguard, and maintain our fleet; international operations; operating hazards present in our and our customers' industries and substantial liability claims; our contracts that can be terminated or downsized by our customers without penalty; our product offering and market expansion; our ability to attract, retain, and develop qualified leaders, key employees, and skilled personnel; expanding our services in the utilities sector, which may require unionized labor; the price and availability of raw materials; inflation; capital investments and business acquisitions; market competition; technological developments and intellectual property; severe weather, natural disasters, and seasonality; public health crises, epidemics, and pandemics; our cost and continued availability of borrowed funds, including noncompliance with debt covenants; environmental laws and regulations; legal compliance; the inherent limitations of insurance coverage; income taxes; cybersecurity incidents or business system disruptions; activist stockholders that may attempt to effect changes at our Company or acquire control over our Company; share repurchases; and our amended and restated bylaws, which could limit our stockholders' ability to obtain what such stockholders believe to be a favorable judicial forum for disputes with us or our directors, officers or other employees. We assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by securities laws. NPK's filings with the Securities and Exchange Commission can be obtained at no charge at as well as through our website at
Business Wire
44 minutes ago
- Business Wire
Dot Ai to Begin Trading on Nasdaq Stock Market
LAS VEGAS--(BUSINESS WIRE)--SEE ID, Inc., doing business as Dot Ai (Nasdaq: DAIC) ('Dot Ai'), a pioneering startup at the forefront of asset intelligence technology, today announced that shares of its Class A common stock and warrants will commence trading on the Nasdaq Stock Market under the ticker symbols 'DAIC' and 'DAICW,' respectively, on June 23, 2025. 'We're thrilled to finalize our listing and to become a publicly traded company,' said Ed Nabrotzky, Co-founder and CEO of Dot Ai. 'Leveraging state-of-the-art artificial intelligence engines, the Internet of Things, and our patented, proprietary and innovative software, hardware and cloud integration solutions, we are revolutionizing how companies all over the world manage their supply chains, logistics operations and operational security.' 'With access to the public markets, we look forward to executing on our growth plans, delivering on our product launches, including our recently announced Zero Infrastructure Mesh and more, and ramping up operations at our Puerto Rico manufacturing hub,' Mr. Nabrotzky continued. 'Furthermore, with partners like Würth Industry USA and additional key players to be announced in the coming months, we believe Dot Ai is well positioned to capitalize on the rapidly increasing demand for modern, next-gen technology that empowers comprehensive, efficient, secure and reliable supply chains across a variety of sectors.' Key Operational Highlights In December 2024, Dot Ai unveiled ZiM (Zero Infrastructure Mesh), a next-gen Internet of Things (IoT) tracking technology, to replace the outdated and expensive technologies that logistics operations have relied on for decades. ZiM is designed to offer an innovative asset management solution by securely gathering data at the edge of the enterprise. It can read both passive (battery free transponders) and active (battery powered beacons) to provide data for supervisory systems. The bridge can operate with its own battery power when mounted on moving racks or pallets or be hardwired to power for fixed installation in aisles or doorways. Puerto Rico Facility In May 2025, in partnership with Invest Puerto Rico ('Invest PR'), the island's business attraction organization, Dot Ai announced plans to establish its first hardware manufacturing operation in Barceloneta. The company chose Puerto Rico to benefit from U.S. jurisdictional protections, strong intellectual property enforcement and access to global markets from a domestic base. Dot Ai projects the facility will result in the creation of up to 200 full-time jobs over the next five years, subject to business conditions and operational scaling. Dot AI's new facility in Barceloneta will manufacture and globally distribute its patented IoT tracking systems, boosting Puerto Rico's reputation as a hub for cutting-edge technology and advanced manufacturing. Partnership with Wurth Industry USA In November 2024, Dot Ai and Würth Industry USA ('Würth'), a leading industrial distributor and division of the Würth Group, announced the execution of a five-year agreement to bring Dot Ai's advanced, AI-driven tracking solutions to Würth's customers. This access offers Würth unprecedented visibility into internal and customer premise operations and provides Dot Ai an exclusive partnership to serve Würth's manufacturing vertical. Under this agreement, Würth customers gain access to Dot Ai's state-of-the-art track and trace technology, including the ZiM Bridge, Industrial Passive asset tag solution (which requires no battery), and a cloud-based, AI platform that continually optimizes processes. These innovations are being seamlessly integrated with Würth's customized CPS ® kanban inventory management solutions, providing real-time data and increasing responsiveness to changing demands, resulting in unprecedented supply chain metrics and security. About Dot Ai At the heart of the technological revolution in asset management and security lies Dot Ai, a trailblazing SaaS service that is redefining the paradigms of asset intelligence, assurance and safety. By harnessing the power of IoT tracking technology, Dot Ai stands at the forefront of innovation, offering patented solutions that are not just advanced but transformative. Through relentless research and development, Dot Ai has pioneered a suite of technologies that empower organizations to not only streamline their logistics and supply chain processes but also bolster operational security to unprecedented levels. Leveraging state-of-the-art AI engines, cutting-edge 5G RF and BLE technology, and seamless cloud integrations, Dot Ai transcends traditional boundaries, offering real-time asset visibility and predictive analytics that integrate effortlessly with existing infrastructure. This is not just technology; it's a vision for a more secure, efficient, and connected world. Discover more about how Dot Ai is leading the charge in asset intelligence by visiting Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts, including the statements regarding the anticipated timing to commence trading on the Nasdaq Stock Market, plans regarding the execution of its growth plans, expectations regarding its ZiM product launch and its Puerto Rico Facility expansion. All forward-looking statements are based on ShoulderUp's current expectations and beliefs concerning future developments and their potential effects on ShoulderUp, SEE ID or any successor entity thereof. Forward-looking statements are based on various assumptions, whether or not identified in this press release, and are subject to risks and uncertainties. These forward-looking statements are not intended to serve as a guarantee of future performance. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) risks that the transaction and listing disrupt current plans and operations of SEE ID, (ii) costs related to the transaction and the failure to realize anticipated benefits of the transaction or to realize estimated pro forma results and underlying assumptions, (iii) the risk that SEE ID and its current and future collaborators are unable to successfully develop and commercialize SEE ID's products or services, or experience significant delays in doing so, (iv) the risk that SEE ID may need to raise additional capital to execute its business plan, which many not be available on acceptable terms or at all, (v) the risk that the post-combination company experiences difficulties in managing its growth and expanding operations. The foregoing list of factors is not exhaustive; (vi) competition, the ability of SEE ID to grow and manage growth profitably, and retain its management and key employees; (vii) changes in applicable laws or regulations; and (viii) weakness in the economy, market trends, uncertainty and other conditions in the markets in which SEE ID operates, and other factors beyond its control, such as inflation or rising interest rates. You should carefully consider the foregoing factors and the other risks and uncertainties described in the 'Risk Factors' section of the S-4 Registration Statement and proxy statement/prospectus discussed above and other documents filed or to be filed by ShoulderUp, SEE ID and/or any successor entity thereof from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and ShoulderUp assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
